Clinical efficacy of surgically assisted transjugular intrahepatic portosystemic shunt for cavernous transformation of portal vein

Figure 2 Survival, hepatic encephalopathy, gastrointestinal rebleeding and liver failure incidence curves between the surgically assisted transjugular intrahepatic portosystemic shunt group and control group. A and B: Incidence curves of liver failure at three and six months in the two groups; C and D: Incidence curves of hepatic encephalopathy at three and six months in the two groups; E and F: Survival curves at three and six months in the two groups; G and H: Incidence curves of gastrointestinal rebleeding at three and six months in the two groups. SATIPS: Surgically assisted transjugular intrahepatic portosystemic shunt.